FTHFX
Price
$53.15
Change
+$3.45 (+6.94%)
Updated
Feb 3 closing price
Net Assets
11.13B
GQSCX
Price
$16.49
Change
+$1.77 (+12.02%)
Updated
Feb 3 closing price
Net Assets
2.64M
Interact to see
Advertisement

FTHFX vs GQSCX

Header iconFTHFX vs GQSCX Comparison
Open Charts FTHFX vs GQSCXBanner chart's image
FullerThaler Behavioral Sm-Cp Eq R6
Price$53.15
Change+$3.45 (+6.94%)
VolumeN/A
Net Assets11.13B
Glenmede Disciplined US Small Cap Eq Ptf
Price$16.49
Change+$1.77 (+12.02%)
VolumeN/A
Net Assets2.64M
FTHFX vs GQSCX Comparison Chart in %
View a ticker or compare two or three
VS
FTHFX vs. GQSCX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTHFX is a Buy and GQSCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTHFX has more cash in the bank: 11.1B vs. GQSCX (2.64M). FTHFX pays higher dividends than GQSCX: FTHFX (0.63) vs GQSCX (0.23). FTHFX was incepted earlier than GQSCX: FTHFX (14 years) vs GQSCX (8 years). GQSCX (3.65) is less costly to investors than FTHFX (0.63). GQSCX is a more actively managed with annual turnover of: 92.00 vs. FTHFX (28.00). GQSCX has a lower initial minimum investment than FTHFX: GQSCX (0) vs FTHFX (1000000). GQSCX annual gain was more profitable for investors over the last year : 17.85 vs. FTHFX (16.23). FTHFX return over 5 years is better than : 72.22 vs. GQSCX (30.52).
FTHFXGQSCXFTHFX / GQSCX
Total Expense Ratio0.630.8574%
Annual Report Gross Expense Ratio0.633.6517%
Fund Existence14 years8 years-
Gain YTD5.0197.00872%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.1B2.64M420,933%
Annual Yield % from dividends0.630.23274%
Returns for 1 year16.2317.8591%
Returns for 3 years40.9425.00164%
Returns for 5 years72.2230.52237%
Returns for 10 years279.59N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL25.771.00
+4.04%
Lyell Immunopharma Inc
RXO15.940.45
+2.91%
RXO
CPHI0.910.01
+1.11%
China Pharma Holdings Inc
PYXS1.49-0.04
-2.61%
Pyxis Oncology
J132.91-3.97
-2.90%
Jacobs Solutions